Imaging study to check liver tumor response to radiation treatment
Part of Cancer clinical trials.
This study uses special MRI scans and PET scans to see how liver tumors respond to a radiation treatment called radioembolization (SIRT). The goal is to improve how treatment response is measured in people with metastatic liver disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have at least one liver tumor that is 1 cm or bigger and visible on a CT or MRI scan
- Your liver tumors show up on a standard PET scan (called FDG-avid)
- You are already scheduled for a SIRT procedure and approved by a team of doctors
- You do not have diabetes
- You are able to lie still for a long time during scanning
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a special type of PET scan (18FET PET) to help find active pituitary tumors when standard MRI images are not clear. This could help doctors decide the best next step, like surgery or radiation, for people with certain hormone-producing tumors.
This trial uses special MRI scans to learn more about liver cancer (hepatocellular carcinoma) before and during treatment with TACE or SIRT. It may help doctors better understand how the tumor responds to therapy.
This trial is for people with liver cancer (hepatocellular carcinoma) who are about to receive a type of internal radiation therapy called TARE (also known as radioembolization). Researchers want to learn more about how the cancer responds to this treatment using scans and biopsies. You might be a good fit if you have not had any prior treatment for your liver cancer.
This trial studies a targeted liver radiation procedure that uses tiny radioactive beads to treat colon cancer spread mostly in the liver. It may help people whose liver tumors cannot be removed or treated with other common local treatments, but it has several safety and “screening” checks.
This early-phase study tests whether a special MRI scan with injected labeled “pyruvate” can act as a biomarker (a measurable sign) for advanced solid tumor activity. It may help doctors see tumor metabolism over time and better track how treatment is affecting cancer.
This trial uses a special PET scan to see how well stereotactic radiotherapy works for brain metastases. You may join if you have at least one brain tumor that your doctor thinks should be treated with this precise type of radiation.
Hear when a new Fluorodeoxyglucose F18 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.